LINFOMAS Y TRASPLANTES
NewYork–Presbyterian Hospital
Nueva York, Estados UnidosPublications in collaboration with researchers from NewYork–Presbyterian Hospital (1)
2021
-
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 2, pp. 97-105